Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Role of Cardiac Energetics in Aortic Stenosis Disease Progression: Identifying the High-risk Metabolic Phenotype.

Journal article

Monga S. et al, (2023), Circ Cardiovasc Imaging, 16

Predictors and clinical implications of residual mitral regurgitation following left ventricular assist device therapy.

Journal article

Sharma H. et al, (2023), Open Heart, 10

Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis.

Journal article

Ashkir Z. et al, (2023), Eur Heart J Cardiovasc Imaging

A rare case of refractory hypoxaemia in a patient with large ostial right coronary artery thrombus and large atrial septal defect.

Journal article

Nikolaidou C. et al, (2023), Eur Heart J Cardiovasc Imaging

Non-invasive cardiovascular magnetic resonance assessment of pressure recovery distance after aortic valve stenosis.

Journal article

Fernandes JF. et al, (2023), J Cardiovasc Magn Reson, 25

A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF FENOFIBRATE AS A METABOLIC MODULATOR TO AUGMENT CARDIAC PHYSIOLOGY IN MODERATE-SEVERE AORTIC STENOSIS

Conference paper

Monga S. et al, (2023), HEART, 109, A23 - A24

Differentiating left ventricular remodelling in aortic stenosis from systemic hypertension and impact of surgical replacement

Preprint

Mahmod M. et al, (2023)

ROLE OF CARDIAC ENERGETICS IN AORTIC STENOSIS DISEASE PROGRESSION: IDENTIFYING THE HIGH-RISK METABOLIC PHENOTYPE

Conference paper

Monga S. et al, (2023), HEART, 109, A22 - A23

Insights Into the Metabolic Aspects of Aortic Stenosis With the Use of Magnetic Resonance Imaging.

Journal article

Monga S. et al, (2022), JACC Cardiovasc Imaging, 15, 2112 - 2126

Left ventricular T1-mapping in diastole versus systole in patients with mitral regurgitation.

Journal article

Liu B. et al, (2022), Sci Rep, 12

Artificial Intelligence for Contrast-Free MRI: Scar Assessment in Myocardial Infarction Using Deep Learning-Based Virtual Native Enhancement.

Journal article

Zhang Q. et al, (2022), Circulation, 146, 1492 - 1503

Measurement of exhaled nitric oxide fails to predict left atrial pressure assessed by E/e ratio in elderly patients.

Journal article

Jones ST. et al, (2022), BJGP Open

Acute vasodilator response testing in the adult Fontan circulation using non-invasive 4D Flow MRI: a proof-of-principle study.

Journal article

McConnell B. et al, (2022), Cardiol Young, 1 - 8

B-Type Natriuretic Peptide at Admission Is a Predictor of All-Cause Mortality at One Year after the First Acute Episode of New-Onset Heart Failure with Preserved Ejection Fraction

Journal article

Ghilencea L-N. et al, (2022), Journal of Personalized Medicine, 12, 890 - 890

United Kingdom standards for non-invasive cardiac imaging: recommendations from the Imaging Council of the British Cardiovascular Society

Journal article

Treibel TA. et al, (2022), Heart

Association of Myocardial Fibrosis and Stroke Volume by Cardiovascular Magnetic Resonance in Patients With Severe Aortic Stenosis With Outcome After Valve Replacement: The British Society of Cardiovascular Magnetic Resonance AS700 Study.

Journal article

Thornton GD. et al, (2022), JAMA Cardiol

A Longitudinal Study of Mitral Regurgitation Detected after Acute Myocardial Infarction.

Journal article

Sharma H. et al, (2022), J Clin Med, 11

Rare congenital quadricuspid pulmonary valve stenosis evaluated by CMR (vol 2020, omaa112, 2020)

Journal article

Nikolaidou C. et al, (2022), OXFORD MEDICAL CASE REPORTS, 2022

A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF FENOFIBRATE AS A METABOLIC MODULATOR TO AUGMENT CARDIAC PHYSIOLOGY IN MODERATE-SEVERE AORTIC STENOSIS

Conference paper

Monga S. et al, (2022), HEART, 108, A1 - A1

A Randomised Double-Blind Placebo-Controlled Study of Fenofibrate as a Metabolic Modulator to Augment Cardiac Physiology in Moderate-Severe Aortic Stenosis

Conference paper

Monga S. et al, (2022), CIRCULATION, 146

Load More